From here:
An Indian panel of ministers has recommended price regulation for 348 "essential
drugs", up from 74 earlier, a federal minister said, a move that is likely to
hit prices of costly brands sold by domestic as well as multi-national
drugmakers.
The panel has finalised the proposal and it will be forwarded to the cabinet
within a week, telecommunications minister Kapil Sibal told reporters on
Thursday.
According to the initial draft, medicines worth 290 billion rupees ($5.42
billion), excluding the retailers' cut, would come under price control. India is
the world's fourth largest drug market by volume and 14th largest by value.
What about profits for Big Pharma? What if other countries will repeat this approach? No, I think Big Pharma will make something in this situation!
No comments:
Post a Comment